Safety Study of Dabigatran in CADASIL

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This study is a Phase II, randomized, crossover trial designed to compare one fixed dose of dabigatran with open-label use of ASA in patients affected by CADASIL; the study is a safety trial, and the primary objective is to assess that dabigatran is not less safe than ASA in subjects with CADASIL.
Epistemonikos ID: 0408bdf9928ab80f0263d463d30bb958f3e4aac6
First added on: May 06, 2024